Results
2469
Stocks with high levels of insider buying the past 3 months and good analyst coverage.
2,469 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
ORCL | US$176.00 | 1.2% | 58.5% | US$507.7b | US$194.64 | PE42.3x | E15.7% | 0.9% | Software | ||
UNH | US$502.42 | -5.4% | -4.6% | US$470.3b | US$637.24 | PE32.1x | E18.8% | 1.7% | Healthcare | ||
JNJ | US$159.68 | 1.5% | -0.5% | US$380.1b | US$168.64 | PE27.3x | E8.4% | 3.1% | Pharmaceuticals & Biotech | ||
HSBA | UK£8.80 | 0.4% | 49.0% | UK£156.4b | UK£9.03 | PB1.1x | E2.0% | 5.9% | Banks | ||
AMD | US$114.17 | 2.1% | -37.2% | US$185.9b | US$148.34 | PE112.7x | E32.0% | n/a | Semiconductors | ||
PFE | US$25.90 | 1.0% | -6.0% | US$146.7b | US$31.18 | PE18.3x | E3.6% | 6.6% | Pharmaceuticals & Biotech | ||
LOW | US$246.42 | -2.5% | 6.9% | US$139.3b | US$282.36 | PE20.4x | E5.8% | 1.9% | Retail | ||
BHP | AU$41.26 | 0.8% | -7.4% | AU$203.7b | AU$44.56 | PE11.8x | E-0.4% | 3.8% | Materials | ||
COP | US$102.00 | 5.3% | -9.1% | US$126.7b | US$129.94 | PE14.1x | E4.5% | 3.1% | Energy | ||
BMY | US$55.79 | -0.3% | 8.7% | US$111.6b | US$61.34 | PS2.3x | E34.4% | 4.4% | Pharmaceuticals & Biotech | ||
TD | CA$85.59 | 0.6% | 5.8% | CA$149.8b | CA$89.27 | PB1.3x | E11.5% | 4.9% | Banks | ||
IBKR | US$226.00 | -3.8% | 111.7% | US$98.3b | US$225.80 | PE32.6x | E2.6% | 0.4% | Diversified Financials | ||
INVE A | SEK 320.00 | 0.1% | 25.4% | SEK 983.2b | SEK 315.00 | PE8.6x | E-48.3% | 1.6% | Diversified Financials | ||
BP. | UK£4.52 | -2.6% | -3.5% | UK£70.8b | UK£4.86 | PE241.8x | E34.5% | 5.6% | Energy | ||
CVS | US$65.09 | -1.9% | -15.6% | US$83.7b | US$72.14 | PE17.8x | E14.4% | 4.1% | Healthcare | ||
ATCO A | SEK 187.40 | -1.0% | 4.3% | SEK 874.5b | SEK 187.05 | PE30.6x | E6.9% | 1.6% | Capital Goods | ||
TRI | CA$250.32 | -1.4% | 17.4% | CA$110.5b | CA$253.24 | PE36.3x | E-1.4% | 1.3% | Commercial Services | ||
ITW | US$265.54 | 2.1% | 2.7% | US$77.5b | US$263.47 | PE22.3x | E1.9% | 2.3% | Capital Goods | ||
1299 | HK$58.00 | 3.0% | -10.4% | HK$587.0b | HK$92.77 | PE16.5x | E13.9% | 2.8% | Insurance | ||
GSK | UK£14.47 | 0.2% | -13.3% | UK£59.1b | UK£17.97 | PE22.9x | E16.9% | 4.2% | Pharmaceuticals & Biotech | ||
CRH | US$102.58 | -3.7% | 31.2% | US$71.8b | US$114.61 | PE20.1x | E9.5% | 1.4% | Materials | ||
SPG | US$186.71 | 0.3% | 23.2% | US$70.1b | US$190.56 | PB21x | E-0.5% | 4.5% | Real Estate | ||
NAB | AU$35.08 | -14.4% | 3.6% | AU$107.5b | AU$34.03 | PB1.7x | E2.1% | 4.8% | Banks | ||
WBC | AU$31.03 | -10.6% | 19.6% | AU$107.0b | AU$29.59 | PB1.5x | E-0.1% | 4.9% | Banks |